The Cell Therapies Platform hosts a biological Isolator that provides a sterile, fully contained environment suitable for the processing of human cells and tissue. This facility has been established to boost the clinical development of human cell-based therapies.
The CTP provides a flexible, cost effective alternative to traditional cell therapy manufacturing facilities. It is available to researchers within and outside the MHTP seeking to translate their human cell and tissue-based therapies to the clinic.
- Prof Graham Jenkin, Ritchie Centre, Hudson Institute, Department of Obstetrics and Gynaecology, Monash University, Ph. +61 3 8572 2801, email@example.com